RHEUMATIC FEVER AS NONVANISHING DISEASE: A PROBLEM STATE AND CLINICAL CASES
https://doi.org/10.20996/1819-6446-2010-6-3-349-358
Abstract
Early diagnostics and treatment of patients with acute rheumatic fever (RF) remains actual problem because rheumatic heart disease is still one of the main causes of acquired valvular lesions. Two cases of acute RF occurred in City Clinical Hospital №1 named after N.I. Pirogov in 2009 are presented. Different outcomes were observed during 6 and 10 months of clinical monitoring. The main approaches to diagnostics and treatment of RF are also described taking into consideration national and international guidelines.
About the Authors
N. A. Shostak
Russian State Medical University
Russian Federation
Russian Federation
Chair of Faculty Therapy named after academician A.I. Nesterov
Ostrovityaninova ul. 1, Moscow, 117997
A. A. Klimenko
Russian State Medical University
Russian Federation
Russian Federation
Chair of Faculty Therapy named after academician A.I. Nesterov
Ostrovityaninova ul. 1, Moscow, 117997
I. V. Novikov
Russian State Medical University
Russian Federation
Russian Federation
Chair of Faculty Therapy named after academician A.I. Nesterov
Ostrovityaninova ul. 1, Moscow, 117997
D. J. Andrijashkina
Russian State Medical University
Russian Federation
Russian Federation
Chair of Faculty Therapy named after academician A.I. Nesterov
Ostrovityaninova ul. 1, Moscow, 117997
M. S. Churilova
Russian State Medical University
Russian Federation
Russian Federation
Chair of Faculty Therapy named after academician A.I. Nesterov
Ostrovityaninova ul. 1, Moscow, 117997
References
1. Анохин В.Н., Новиков Ю.И., Стулова М.А. Современные представления о патогенезе ревматизма. Вопросы ревматизма 1980;2:3-7.
2. Полубенцева Е.И., Анохин В.Н. Течение и исходы ревматического кардита (клинико-эхокардиологическое исследование). Ревматология 1986; 4:3-10.
3. Нестеров А.И. Ревматизм. М.: Медицина; 1973.
4. Stollerman G.H. Rheumatic fever in the 21st century. Clin Infect Dis 2001;33(6): 806-814.
5. Насонова В.А. Ревматическая лихорадка (ревматизм) в ХХ веке. Терапевтический архив 1998;9:41-44.
6. Аксенова А.В., Брико Н.И., Клейменов Д.А. Динамика эпидемиологических показателей острой ревматической лихорадки в Москве и Российской Федерации с 1996 г. по 2007 г. Вестник РГМУ 2009; 7:10-15.
7. The current evidence for the burden of group A streptococcal diseases. Geneva, World Health Organisation, 2005. Available on http://whqlibdoc.who.int/hq/2005/ WHO_FCH_CAH_05.07.pdf
8. Burge D.J., DeHoratius R.J. Acute Rheumatic Fever. Cardiovasc Clin 1993; 23: 3-23.
9. Белов Б.С., Гришаева Т.П. Острая ревматическая лихорадка: современные подходы к первичной и вторичной профилактике. Лечащий врач 2007;6: 99-101.
10. Фоломеева О.М., Галушко Е.А., Эрдес Ш.Ф. Распространенность ревматических заболеваний в популяциях взрослого населения России и США. Научно-практическая ревматология 2008;4:4-13.
11. Заболеваемость населения России в 2006 году. Статистические материалы. Часть I. Министерство здравоохранения и социального развития Российской Федерации. М.: 2007.
12. Denny F.W. T. Duckett Jones and Rheumatic Fever in 1986. T. Duckett Jones Memorial Lecture. Circulation 1987; 76(5):963-970.
13. Ferrieri Р. and forthe Jones Criteria Working Group. Proceedings of the Jones Criteria Workshop. Circulation 2002; 106(19):2521-2523.
14. Working Group on Pediatric Acute Rheumatic Fever and Cardiology Chapter of Indian Academy of Pediatrics. Consensus Guidelines on PediatricAcute Rheumatic Fever and Rheumatic Heart Disease. Indian Pediatrics 2008; 45(7):565-573.
15. Olivier C. Rheumatic fever – is there still a problem? J Antimicrob Chemother 2000; 45 Suppl: 13-21.
16. Шостак Н.А. Ревматический кардит: клинико-морфологическая диагностика, лечение, профилактика. Врач 2004; 4: 5-9.
17. Report of a WHO Expert Consultation WHO Technical Report Series, №923. Rheumatic Fever and Rheumatic Heart Disease. Geneva, 2004. Available on http://www.who.int/entity/cardiovascular_diseases/resources/en/cvd_trs923.pdf
18. New Zealand Guidelines for Rheumatic Fever. Diagnosis, Management and Secondary Prevention. The NationalHealth Foundation of New Zealand, 2008. Available on http://www.nhf.org.nz/files/Rheumatic%20fever%20guideline%201.pdf
19. Marijon E., Celermajer D.S., Tafflet M. et al. Rheumatic Heart Disease Screening by Echocardiography: The Inadequacy of World Health Organization Criteria for Optimizing the Diagnosis of Subclinical Disease. Circulation 2009;120:663-668.
20. Carapetis J.R., Brown A., Wilson N.J., Edwards K.N.; Rheumatic Fever Guidelines Writing Group. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. The Medical Journal of Australia 2007;186(11): 581-586.
21. Taranta A. Rheumatic fever: Clinical aspects. In: Hollander J.L., McCarty D.J., Jr, eds. Arthritis and Allied Conditions. 8th ed. Philadelphia: Lea & Febiger; 1972.
22. Абельдяев Д.В., Шостак Н.А., Карпова Н.Ю. и соавт. Постстрептококковый артрит. Научно-практическая ревматология 2003;4:77-82.
23. Schaffer F.M., Agarwal R., Helm J et al. Poststreptococcal reactive arthritis and silent carditis: a case report and review of the literature. Pediatrics 1994;93(5):837- 839.
24. Насонов Е.Л., редактор.Клинические рекомендации. Ревматология. М.: ГЭО- ТАР-Медиа; 2008.
25. Braunwald E., Zipes D.P., Libby P.Heart Disease: Atextbook of Cardiovascular Medicine, 6th edition. Philadelphia: W.B. Saunders Company; 2001.
Review
For citations:
Shostak N.A., Klimenko A.A., Novikov I.V., Andrijashkina D.J., Churilova M.S. RHEUMATIC FEVER AS NONVANISHING DISEASE: A PROBLEM STATE AND CLINICAL CASES. Rational Pharmacotherapy in Cardiology. 2010;6(3):349-358. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-3-349-358
Views:
758
Email this article 